RICCARDI, CONSIGLIA
RICCARDI, CONSIGLIA
Dipartimento di Medicina Sperimentale
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database
2023 Ruggiero, R.; Donniacuo, M.; Mascolo, A.; Gaio, M.; Cappetta, D.; Rafaniello, C.; Docimo, G.; Riccardi, C.; Izzo, I.; Ruggiero, D.; Paolisso, G.; Rossi, F.; De Angelis, A.; Capuano, A.
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management
2023 Ruggiero, R.; Di Napoli, R.; Balzano, N.; Ruggiero, D.; Riccardi, C.; Anatriello, A.; Cantone, A.; Sportiello, L.; Rossi, F.; Capuano, A.
Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria
2023 Liguori, V.; Zinzi, A.; Gaio, M.; Riccardi, C.; Di Costanzo, L.; Gargano, F.; Carpentieri, C.; D'Elia, M.; Bernardi, F. F.; Trama, U.; Capuano, A.; Rafaniello, C.
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis
2024 Gaio, M.; Vastarella, M. G.; Sullo, M. G.; Scavone, C.; Riccardi, C.; Campitiello, M. R.; Sportiello, L.; Rafaniello, C.
The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database
2023 Liguori, V.; Gaio, M.; Zinzi, A.; Cagnotta, C.; Riccardi, C.; Docimo, G.; Capuano, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database | 1-gen-2023 | Ruggiero, R.; Donniacuo, M.; Mascolo, A.; Gaio, M.; Cappetta, D.; Rafaniello, C.; Docimo, G.; Riccardi, C.; Izzo, I.; Ruggiero, D.; Paolisso, G.; Rossi, F.; De Angelis, A.; Capuano, A. | |
| Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management | 1-gen-2023 | Ruggiero, R.; Di Napoli, R.; Balzano, N.; Ruggiero, D.; Riccardi, C.; Anatriello, A.; Cantone, A.; Sportiello, L.; Rossi, F.; Capuano, A. | |
| Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria | 1-gen-2023 | Liguori, V.; Zinzi, A.; Gaio, M.; Riccardi, C.; Di Costanzo, L.; Gargano, F.; Carpentieri, C.; D'Elia, M.; Bernardi, F. F.; Trama, U.; Capuano, A.; Rafaniello, C. | |
| Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis | 1-gen-2024 | Gaio, M.; Vastarella, M. G.; Sullo, M. G.; Scavone, C.; Riccardi, C.; Campitiello, M. R.; Sportiello, L.; Rafaniello, C. | |
| The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database | 1-gen-2023 | Liguori, V.; Gaio, M.; Zinzi, A.; Cagnotta, C.; Riccardi, C.; Docimo, G.; Capuano, A. |